|
Study | Number of positive cases (%) |
NG (%) | CT (%) | HSV (%) |
|
Our study, Dubai, UAE | 5.5 | 10.5 | 6.5 |
Simms et al. (2003), UK [3] | — | 27 | — |
Vahidnia et al. (2013), Amsterdam, The Netherlands [8] | — | — | 5.26 (HSV-1) 4.31 (HSV-2) |
Xu et al. (2006), USA [9] | — | — | 57.7 (HSV-1) 17.0 (HSV-2) |
Wang et al. (2012), China, Hekou, Yunnan Province [10] | — | — | 58.3 (HSV-2) |
Aumakhan et al. (2010), USA [11] | — | — | 7 (HSV-2) |
Miller et al. (2000), USA [12] | — | 7.8 | — |
Geraats-Peters et al. (2005), The Netherlands [14] | 30 | — | — |
Tosun et al. (2008), Turkey [16] | — | 12.7 | — |
Gaydos et al. (2010), USA [17] | 3.8 | 8.9 | — |
Wang et al. (2008), China, Yunnan Province [18] | 8 | 26 | 68 (HSV-2) |
Cárcamo et al. (2012), Peru [19] | 0.1 | 6.5 | 13.6 (HSV-2) |
Choi et al. (2012), South Korea [20] | — | 2.4 | 0.8 (HSV-2) |
Znazen et al. (2010), Tunisia [21] | 11.2 | 72.9 | 1.1 (HSV-2) |
Bogaerts et al. (2001), Dhaka, Bangladesh [22] | — | — | 12 (HSV-2) |
Franceschi et al. (2007), Spain and Nigeria [23] | 0.2–6 | 0.2–5.6 | — |
Madhivanan et al. (2008), Mysore, India [24] | — | 8.2 | 11.2 (HSV-2) |
|